Duchenne Muscular Dystrophy Therapeutics Market - Forecast(2024 - 2030)

Report Code: HCR 84496 Report Format: PDF + Excel
1. Duchenne Muscular Dystrophy Therapeutics Market - Overview
        1.1 Definitions and Scope
2. Duchenne Muscular Dystrophy Therapeutics Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Duchenne Muscular Dystrophy Therapeutics Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Duchenne Muscular Dystrophy Therapeutics Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Duchenne Muscular Dystrophy Therapeutics Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Duchenne Muscular Dystrophy Therapeutics Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Duchenne Muscular Dystrophy Therapeutics Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Duchenne Muscular Dystrophy Therapeutics Market - By Treatment Type (Market Size -$Million / $Billion)
8.1 Cortecosteroids
8.1.1 Prednisolone
8.1.2 Prednisone
8.1.3 Deflazacort
9. Duchenne Muscular Dystrophy Therapeutics Market - By End User (Market Size -$Million / $Billion)
9.1 Hospital
9.2 Clinic
9.3 Home Care Setting
10. Duchenne Muscular Dystrophy Therapeutics- By Geography (Market Size -$Million / $Billion)
        10.1 Duchenne Muscular Dystrophy Therapeutics Market - North America Segment Research
        10.2 North America Market Research (Million / $Billion)
            10.2.1 Segment type Size and Market Size Analysis
            10.2.2 Revenue and Trends
            10.2.3 Application Revenue and Trends by type of Application
            10.2.4 Company Revenue and Product Analysis
            10.2.5 North America Product type and Application Market Size
                  10.2.5.1 U.S
                  10.2.5.2 Canada
                  10.2.5.3 Mexico
                  10.2.5.4 Rest of North America
        10.3 Duchenne Muscular Dystrophy Therapeutics- South America Segment Research
        10.4 South America Market Research (Market Size -$Million / $Billion)
            10.4.1 Segment type Size and Market Size Analysis
            10.4.2 Revenue and Trends
            10.4.3 Application Revenue and Trends by type of Application
            10.4.4 Company Revenue and Product Analysis
            10.4.5 South America Product type and Application Market Size
                  10.4.5.1 Brazil
                  10.4.5.2 Venezuela
                  10.4.5.3 Argentina
                  10.4.5.4 Ecuador
                  10.4.5.5 Peru
                  10.4.5.6 Colombia
                  10.4.5.7 Costa Rica
                  10.4.5.8 Rest of South America
        10.5 Duchenne Muscular Dystrophy Therapeutics- Europe Segment Research
        10.6 Europe Market Research (Market Size -$Million / $Billion)
            10.6.1 Segment type Size and Market Size Analysis
            10.6.2 Revenue and Trends
            10.6.3 Application Revenue and Trends by type of Application
            10.6.4 Company Revenue and Product Analysis
            10.6.5 Europe Segment Product type and Application Market Size
                  10.6.5.1 U.K
                  10.6.5.2 Germany
                  10.6.5.3 Italy
                  10.6.5.4 France
                  10.6.5.5 Netherlands
                  10.6.5.6 Belgium
                  10.6.5.7 Denmark
                  10.6.5.8 Spain
                  10.6.5.9 Rest of Europe
        10.7 Duchenne Muscular Dystrophy Therapeutics - APAC Segment Research
        10.8 APAC Market Research (Market Size -$Million / $Billion)
            10.8.1 Segment type Size and Market Size Analysis
            10.8.2 Revenue and Trends
            10.8.3 Application Revenue and Trends by type of Application
            10.8.4 Company Revenue and Product Analysis
            10.8.5 APAC Segment - Product type and Application Market Size
                  10.8.5.1 China
                  10.8.5.2 Australia
                  10.8.5.3 Japan
                  10.8.5.4 South Korea
                  10.8.5.5 India
                  10.8.5.6 Taiwan
                  10.8.5.7 Malaysia
                  10.8.5.8 Hong kong
                  10.8.5.9 Rest of APAC
        10.9 Duchenne Muscular Dystrophy Therapeutics - Middle East Segment and Africa Segment Research
        10.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            10.10.1 Segment type Size and Market Size Analysis
            10.10.2 Revenue and Trend Analysis
            10.10.3 Application Revenue and Trends by type of Application
            10.10.4 Company Revenue and Product Analysis
            10.10.5 Middle East Segment Product type and Application Market Size
                  10.10.5.1 Israel
                  10.10.5.2 Saudi Arabia
                  10.10.5.3 UAE
            10.10.6 Africa Segment Analysis
                  10.10.6.1 South Africa
                  10.10.6.2 Rest of Middle East & Africa
11. Duchenne Muscular Dystrophy Therapeutics Market - Entropy
        11.1 New product launches
        11.2 M&A s, collaborations, JVs and partnerships
12. Duchenne Muscular Dystrophy Therapeutics Market - Industry / Segment Competition landscape Premium
        12.1 Market Share Analysis
            12.1.1 Market Share by Country- Top companies
            12.1.2 Market Share by Region- Top 10 companies
            12.1.3 Market Share by type of Application - Top 10 companies
            12.1.4 Market Share by type of Product / Product category- Top 10 companies
            12.1.5 Market Share at global level - Top 10 companies
            12.1.6 Best Practises for companies
13. Duchenne Muscular Dystrophy Therapeutics Market - Key Company List by Country Premium
14. Duchenne Muscular Dystrophy Therapeutics Market Company Analysis
        14.1 Market Share, Company Revenue, Products, M&A, Developments
        14.2 Bristol-Myers Squibb Company
        14.3 Fibrogen, Inc
        14.4 Italfarmaco S P A
        14.5 Marathon Pharmaceuticals, Llc
        14.6 N Pharma, Inc
        14.7 Pfizer Inc
        14.8 Ptc Therapeutics, Inc
        14.9 Reveragen Biopharma, Inc
        14.10 Santhera Pharmaceutical
        14.11 Sarepta Therapeutics, Inc
        14.12 Company 11
        14.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
15. Duchenne Muscular Dystrophy Therapeutics Market - Appendix
        15.1 Abbreviations
        15.2 Sources
16. Duchenne Muscular Dystrophy Therapeutics Market - Methodology
        16.1 Research Methodology
            16.1.1 Company Expert Interviews
            16.1.2 Industry Databases
            16.1.3 Associations
            16.1.4 Company News
            16.1.5 Company Annual Reports
            16.1.6 Application Trends
            16.1.7 New Products and Product database
            16.1.8 Company Transcripts
            16.1.9 R&D Trends
            16.1.10 Key Opinion Leaders Interviews
            16.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
1.1 Pain Management Druds Market 2023-2030 ($M) - Global Industry Research
1.2 Cortecosteroids Market 2023-2030 ($M) - Global Industry Research
1.2.1 Prednisolone Market 2023-2030 ($M)
1.2.2 Prednisone Market 2023-2030 ($M)
1.2.3 Deflazacort Market 2023-2030 ($M)
2.Global Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
2.1 Hospital Market 2023-2030 ($M) - Global Industry Research
2.2 Clinic Market 2023-2030 ($M) - Global Industry Research
2.3 Home Care Setting Market 2023-2030 ($M) - Global Industry Research
3.Global Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 (Volume/Units)
3.1 Pain Management Druds Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Cortecosteroids Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Prednisolone Market 2023-2030 (Volume/Units)
3.2.2 Prednisone Market 2023-2030 (Volume/Units)
3.2.3 Deflazacort Market 2023-2030 (Volume/Units)
4.Global Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 (Volume/Units)
4.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Home Care Setting Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
5.1 Pain Management Druds Market 2023-2030 ($M) - Regional Industry Research
5.2 Cortecosteroids Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Prednisolone Market 2023-2030 ($M)
5.2.2 Prednisone Market 2023-2030 ($M)
5.2.3 Deflazacort Market 2023-2030 ($M)
6.North America Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
6.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
6.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
6.3 Home Care Setting Market 2023-2030 ($M) - Regional Industry Research
7.South America Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
7.1 Pain Management Druds Market 2023-2030 ($M) - Regional Industry Research
7.2 Cortecosteroids Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Prednisolone Market 2023-2030 ($M)
7.2.2 Prednisone Market 2023-2030 ($M)
7.2.3 Deflazacort Market 2023-2030 ($M)
8.South America Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
8.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
8.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
8.3 Home Care Setting Market 2023-2030 ($M) - Regional Industry Research
9.Europe Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
9.1 Pain Management Druds Market 2023-2030 ($M) - Regional Industry Research
9.2 Cortecosteroids Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Prednisolone Market 2023-2030 ($M)
9.2.2 Prednisone Market 2023-2030 ($M)
9.2.3 Deflazacort Market 2023-2030 ($M)
10.Europe Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
10.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
10.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
10.3 Home Care Setting Market 2023-2030 ($M) - Regional Industry Research
11.APAC Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
11.1 Pain Management Druds Market 2023-2030 ($M) - Regional Industry Research
11.2 Cortecosteroids Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Prednisolone Market 2023-2030 ($M)
11.2.2 Prednisone Market 2023-2030 ($M)
11.2.3 Deflazacort Market 2023-2030 ($M)
12.APAC Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
12.3 Home Care Setting Market 2023-2030 ($M) - Regional Industry Research
13.MENA Global Duchenne Muscular Dystrophy Therapeutic Market, By Treatment Type Market 2023-2030 ($M)
13.1 Pain Management Druds Market 2023-2030 ($M) - Regional Industry Research
13.2 Cortecosteroids Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Prednisolone Market 2023-2030 ($M)
13.2.2 Prednisone Market 2023-2030 ($M)
13.2.3 Deflazacort Market 2023-2030 ($M)
14.MENA Global Duchenne Muscular Dystrophy Therapeutic Market, By End User Market 2023-2030 ($M)
14.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
14.2 Clinic Market 2023-2030 ($M) - Regional Industry Research
14.3 Home Care Setting Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
2.Canada Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
12.France Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
16.China Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
17.India Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Duchenne Muscular Dystrophy Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Duchenne Muscular Dystrophy Therapeutics By Application
22.South America Duchenne Muscular Dystrophy Therapeutics By Application
23.Europe Duchenne Muscular Dystrophy Therapeutics By Application
24.APAC Duchenne Muscular Dystrophy Therapeutics By Application
25.MENA Duchenne Muscular Dystrophy Therapeutics By Application
26.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Fibrogen, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Italfarmaco S P A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Marathon Pharmaceuticals, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.N Pharma, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Ptc Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Reveragen Biopharma, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Santhera Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Sarepta Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)